(TBPS), a derivative of potent GABA antagonistic cage con-
NaCl the apparent affinity of [""SITBPS binding sites is lower (Kd 60 + 5 nM), and muscimol has biphasic effects with stimulation at low concentrations of muscimol (EC,, 0. modulated by the occupancy of benzodiazepine receptors with agonists or with inverse agonists. These observations are not compatible with the concept that these CNS depressants and CNS convulsants act on an identical drug receptor.
There is evidence from biochemical and electrophysipharmacological effects in the brain by enhancing the ological experiments that benzodiazepines exert their actions of the inhibitory neurotransmitter GABA (Costa --et al., 1975; Haefely et al., 1975) . Later, benzodiazepines ' To whom correspondence should be addressed.
have been shown to interact with their brain-specific Vol. 4, No. 5, May 1984 drug receptors (Mohler and Okada, 1977; Squires and Braestrup, 1977) , which appear to be constituents of certain types of GABA receptors (Karobath and Sperk, 1979; Tallmann et al., 1978) , the GABA-benzodiazepinechloride ionophore receptor complex (Supavilai and Karobath, 1981; Olsen and Leeb-Lundberg, 1981) . The investigation of GABA and benzodiazepine binding sites and their interactions with the various components of the GABA benzodiazepine receptor complex has been possible by the availability of suitable ligands for these binding sites. However, the investigation of the drug receptor of GABA-regulated chloride ion channels has been very difficult since the only available ligand, ["HI dihydropicrotoxinin, has very high unspecific binding to brain membrane fractions (Ticku et al., 1978) . But recently Squires et al. (1983) have investigated the binding of [""S]-t-butylbicyclophosphorothionate ( [35S] TBPS), a derivative of a series of potent GABA antagonistic cage convulsants (Bowery et al., 1976) . They demonstrated that [""SITBPS binds with high affinity to brain-specific binding sites linked to GABA receptors with biochemical and pharmacological properties similar, but not identical, to ["Hldihydropicrotoxinin binding sites (Squires et al., 1983) . We now report that these ["5S]TBPS binding sites are subject to allosteric modulations by drugs which act at the GABA-benzodiazepine-chloride ionophore receptor complex.
Materials
and Methods Membrane preparation.
Membranes from the cerebral cortex of male Wistar rats (150 to 200 gm) were prepared by homogenization and recentrifugation at least five times with ice-cold 50 mM Tris-HCl buffer, pH 7.1, as described in detail eslewhere (Placheta and Karobath, 1980) . These membrane suspensions were kept frozen overnight and were used for binding experiments after one further centrifugation in 50 mM Tris-citrate buffer, pH 7.5.
In some experiments, aliquots of the membranes were pretreated with 0.05% Triton X-100 as described (Placheta and Karobath, 1980) . In other experiments, aliquots of the membrane fractions resuspended in 50 mM Triscitrate buffer were pre-incubated for 15 min at 23°C with 100 PM AgN03, washed twice in the same buffer at O"C, and then used for binding experiments (Supavilai et al., 1982) . Pretreatment of membranes by photoaffinity labeling with 20 nM unlabeled flunitrazepam was performed by incubating membrane suspensions in ice-cold 50 mM Tris-citrate buffer, pH 7.5, for 20 min in the absence (controls) or presence of long wavelength UV light (Karobath and Supavilai, 1982) . Membrane suspensions were then washed twice in 50 mM Tris-citrate buffer, pH 7.5, to remove nonincorporated flunitrazepam (Hirsch, 1982) .
Standard r"S]TBPS binding procedure. Membrane suspensions containing the equivalent of about 4 mg of fresh tissue were incubated essentially as described by Squires et al. (1983) methyl-P-carboline-3-carboxylate (fl-CCM), ethyl-P-carboline-3-carboxylate (P-CCE), p-carboline-3-carboxyl acid ethyl ester methylamide (FG 7142), and 6,7-dimethoxy-4-ethyl-P-carboline-3-carbox- (Fig. 1) . However, when NaBr is reduced to 100 mM (not shown) or when it is replaced by 200 mM NaCl, biphasic actions of muscimol with high affinity stimulation (EC5o 23 + 4 nM; mean + SEM; n = 10) and low affinity inhibition (IC5,, 724 + 69 nM; n = 10) are observed ( (Fig. 2) .
Influence of the occupancy of benzodiazepine receptors. Recently it has been proposed that drugs acting on benzodiazepine receptors can have agonistic (benzodiazepine-like) effects or inverse benzodiazepine agonistic effects (like some ,&carbolines and DMCM) (Pole et al., 1982) . In addition, a third class of ligands has been proposed, the benzodiazepine receptor antagonists, which have no marked pharmacological effects of their own but which antagonize the actions of benzodiazepine receptor agonists and of inverse benzodiazepine receptor agonists (Pole et al., 1982 (Table I) , but it is able to antagonize the stimulatory action of flunitrazepam and the inhibitory effects of DMCM (Fig. 3) . The latter compound, like P-CCM, in high concentrations inhibits [35S]TBPS binding to a lesser extent than at lower concentrations (Table I) . (Leeb-Lundberg et al., 1980; Squires et al., 1983) , has been shown to perturb GABA and benzodiazepine receptor binding (Beer et al., 1978; Williams and Risley, 1979) at a site which is sensitive to antagonism by picrotoxin and cage convulsants (Supavilai and Karobath, 1979; Leeb-Lundberg et al., 1981 (Fig. 4) trations (I& 12.9 f 3 PM; n = 3 and 550 + 50 PM; n = 3, respectively) (Fig. 4) . The Hill number for etazolate inhibition is 1.5 f 0.1 (n = 5), and that for pentobarbital inhibition is 2.7 f 0.2 (n = 5). The inhibitory effects of pentobarbital occur at high concentrations, which may lead to an unspecific pertubation of membranes. Therefore, we have investigated [35S]TBPS binding after exposure of membrane fractions with even higher concentrations of pentobarbital (incubation for 30 min at 23°C with 2 mM pentobarbital followed by two washings in order to remove potential dissociated membrane constituents and pentobarbital) and find unchanged binding after this procedure (Table III) . In contrast to the CNS (Fig. 5) . These observations indicate differences in the interaction of CNS depressants and CNS convulsants with [""SITBPS binding sites.
Such (Fig. 7) .
Influence of photoaffinity labeling of benzodiazepine receptors with flunitrazepam.
The irreversible binding of flunitrazepam by photoaffinity labeling into one of the four postulated benzodiazepine binding sites of the GABA benzodiazepine receptor complex (Mohler et al., 1980) leads to changes in the properties of the three remaining sites (Hirsch, 1982) . The affinity of benzodiazepines is decreased about loo-fold, whereas that of benzodiazepine receptor antagonists or of inverse benzodiazepine receptor agonists is not markedly altered (Karobath and Supavilai, 1982) . Thus, if [35S]TBPS labels a drug receptor of the GABA benzodiazepine receptor complex, then photoaffinity labeling with flunitrazepam should inhibit the allosteric effects of flunitrazepam on [""SITBPS binding. The results of such experiments with photoaffinity-labeled membranes demonstrate that flunitrazepam, in concentrations which are effective in untreated membranes (Fig. l) , has lost its ability to alter muscimol inhibition of ["5S]TBPS binding (Fig. 8) and to alter base line [3"S]TBPS binding (Table  III) , whereas the effects of DMCM are not altered (Fig.  8) .
Influence of pretreatment of membranes with AgN03 or with Triton X-100. Pretreatment of membranes with AgN03, followed by subsequent washing to remove nonbound Ag+ ions, has been shown to perturb the GABA benzodiazepine receptor complex. Only high affinity [3H] muscimol binding can be found in such membranes, and muscimol stimulates benzodiazepine receptor binding with high affinity (Supavilai et al., 1982) . In addition, CNS depressants and CNS convulsants have lost their ability to modulate ["Hlmuscimol binding and base line or muscimol-stimulated ["Hlflunitrazepam binding (Supavilai et al., 1982) . The investigation of [35S]TBPS binding to such AgN03-pretreated membrane reveals an almost quantitative loss of these binding sites (Table  III) . Pretreatment of membranes with Triton X-100 is another perturbation of the GABA benzodiazepine receptor complex which leads to high affinity [3H]muscimol binding, high affinity stimulation of benzodiazepine binding by GABA (Massotti and Guidotti, 1980) (Supavilai and Karobath, 1980; Supavilai et al., 1982) . In such membranes no [35S]TBPS binding sites are detectable.
These observations confirm and extend the results of Squires et al. (1983) , but there are distinct differences of [35S]TBPS binding sites in our hands. These include the biphasic actions of a number of agents and differences in the affinity of drugs for [35S]TBPS binding sites. The reason(s) for these differences is not known but may be related to the different modes of membrane preparations. We investigated membranes which had repeatedly been washed in buffered solution and which have been shown to reveal allosteric interactions between the different constituents of the GABA benzodiazepine receptor complex (Supavilai et al., 1982) . On the other hand, Squires et al. (1983) In the absence of such perturbing factors, a GABA binding site with low apparent affinity is linked to benzodiazepine receptors (Tallman et al., 1978; Karobath and Sperk, 1979) .
The present observations with CNS depressants are difficult to reconcile with the concept of one common drug receptor for those CNS depressants and those CNS convulsants which are thought to exert their pharmacological effects by altering GABA-regulated chloride conductance mechanisms. The biphasic actions of etazolate and of pentobarbital and the Hill number >l for their inhibitory effects point to a multiplicity of [35S]TBPS binding sites in a GABA benzodiazepine receptor complex, with cooperativity between these sites. That multiple drug receptors may occur in the GABA benzodiazepine receptor complex has already been suggested by Mohler et al. (1980) , who obtained evidence for the existence of four benzodiazepine binding sites per receptor complex. Alternatively, CNS depressants which prolong the opening time of GABA-regulated chloride ion channels (Study and Barker, 1981) and CNS convulsants which decrease permeability at these channels (Barker and MacDonald, 1980) may exert their pharmacological effects at similar but not identical drug receptors. More experimental data are required before these speculations can be confirmed or dismissed.
Finally, the bidirectional effects of ligands for benzodiazepine receptors on baseline or muscimol-inhibited [35S]TBPS binding can be used as a simple in vitro test system to indicate whether a given ligand for benzodiazepine receptors has agonistic or inverse agonistic effects in vivo. With the 14 compounds investigated, there appears to be a good agreement between the present in vitro observations and the pharmacological action of these drugs in uiuo (Jensen et al., 1983) . These results support the concept that drugs acting on benzodiazepine receptors may exhibit a spectrum from full agonists to partial agonists and (partial) inverse agonists (Pole et al., 1982) .
